GROWTHPOINT PPTYS Logo
ZAE000179420
A1W3J7
GRT.JO

GROWTHPOINT PPTYS

Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.


  • Growthpoint raises dividend for 2026, warns of weaker growth in 2027

    Growthpoint increased distributable earnings per share by 4.3% to 152.6 cents and raised the dividend for 2026 by 7.4% to 133 cents. Net asset value per share rose by 3.8%, the loan-to-value ratio improved to 38.7%; net rental income in South Africa grew like-for-like by 4.4%. For 2027 management now forecasts only 1–3% dividend growth, citing the weak office market in Gauteng, slower reinvestment after disposals and higher financing costs as headwinds. » Mere på de.investing.com


  • Growthpoint sells entire 14.2% stake in NewRiver REIT for £50.5 million

    Growthpoint Properties Limited has completed the sale of its entire 14.2% stake in NewRiver REIT plc, disposing of 67.4 million ordinary shares at 75 pence each for gross proceeds of £50.5 million. The placing was conducted, according to the announcement, with strong interest from existing and new investors; Panmure Liberum Limited acted as sole bookrunner and settlement is scheduled for 15 August 2025. NewRiver REIT itself will receive no proceeds from the transaction, as it was a sale of Growthpoint’s existing shares. » Mere på de.investing.com


  • Growthpoint plans sale of around 47.7 million NewRiver shares at 75p each

    Growthpoint Properties Limited will sell approximately 47.7 million ordinary shares of NewRiver REIT plc in an accelerated bookbuild at 75 pence per share, representing most of its previous 14.2% holding. NewRiver has said it intends to buy back up to around 47.7 million of the placed shares; Panmure Liberum is sole bookrunner and NewRiver will receive no proceeds from the secondary placing. The announcement was published as inside information under the UK Market Abuse Regulations, and the final placing result will be announced after the bookbuild is complete. » Mere på de.investing.com

I 2026 har GROWTHPOINT PPTYS allerede udloddet 0,0708 € i udbytte. Den seneste udlodning fandt sted i oktober.

Virksomhedstal

I det seneste kvartal havde GROWTHPOINT PPTYS en omsætning på 327,8 mio. € og et nettoresultat på 275,82 mio. €
(EUR) juni 2026
YoY
Omsætning 327,8 mio. -
Bruttofortjeneste 181,17 mio. -
Nettoresultat 275,82 mio. -
EBITDA 451,16 mio. -

Fundamentale data

Nøgletal Værdi
Markedsværdi
2,85 mia. €
Antal aktier
33,86 mio.
Højeste/laveste i 52 uger
102,27 € - 82,05 €
Udbytteafkast
8,34 %
Udbytte TTM
0,0709 €
Beta
0,58
P/E (PE Ratio)
7,03
PEG (PEG Ratio)
0,16
K/I (PB Ratio)
0,76
P/S (PS Ratio)
4,11

Virksomhedsprofil

Growthpoint er den største primære JSE-noterede REIT i Sydafrika med en kvalitetsportefølje på 440 direkte ejede ejendomme i Sydafrika (RSA) med en værdi på R73,4 mia., herunder fire hospitaler og ét medicinsk center med en værdi på R2,6 mia., ejet af Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint har en aktieandel på 61,8 % i GHPH. Vi har en 62,2 % andel i ASX-noterede Growthpoint Properties Australia Limited (GOZ), som ejer 58 ejendomme i Australien med en værdi på R51,8 mia., og en 52,1 % andel i LSE-noterede Capital & Regional Plc (C&R), som ejer syv ejendomme i Storbritannien med en værdi på R14,8 mia.

Navn
GROWTHPOINT PPTYS
CEO
Estienne Konrad de Klerk
Hjemsted Sandton, gp
Sydafrika
Websted
Børsnotering
11.04.2018
Medarbejdere 634

Tickersymboler

Børs Symbol
Jnb
GRT.JO
Pnk
GWWTF
Frankfurt
G5JA.F
München
G5JA.MU
🍪

Parqet  bruger cookies. Læs mere